Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
227.86
-0.04 (-0.02%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25,150 | 19,088 | 16,745 | 15,305 | 17,365 | 20,588 | |
Market Cap Growth | 26.39% | 13.99% | 9.41% | -11.86% | -15.66% | 29.90% |
Enterprise Value | 30,928 | 25,166 | 23,239 | 20,099 | 21,786 | 24,491 |
Last Close Price | 227.86 | 173.53 | 150.86 | 137.88 | 156.44 | 173.01 |
PE Ratio | 24.20 | 19.83 | 19.62 | 18.41 | 19.63 | 11.13 |
Forward PE | 20.03 | 17.07 | 15.97 | 15.53 | 18.91 | 18.61 |
PEG Ratio | 2.04 | 2.04 | 2.42 | 13.49 | 13.49 | 13.49 |
PS Ratio | 2.18 | 1.73 | 1.70 | 1.65 | 1.76 | 1.91 |
PB Ratio | 3.33 | 2.66 | 2.47 | 2.43 | 2.95 | 3.19 |
P/FCF Ratio | 18.64 | 14.05 | 18.42 | 17.71 | 13.22 | 11.25 |
P/OCF Ratio | 13.22 | 10.12 | 12.55 | 12.03 | 10.11 | 9.22 |
EV/Sales Ratio | 2.68 | 2.28 | 2.35 | 2.17 | 2.20 | 2.27 |
EV/EBITDA Ratio | 13.12 | 11.84 | 12.64 | 11.82 | 11.68 | 8.78 |
EV/EBIT Ratio | 18.97 | 16.17 | 17.27 | 15.93 | 15.26 | 10.29 |
EV/FCF Ratio | 22.93 | 18.52 | 25.57 | 23.26 | 16.58 | 13.38 |
Debt / Equity Ratio | 0.78 | 0.78 | 0.89 | 0.77 | 0.74 | 0.69 |
Debt / EBITDA Ratio | 2.71 | 3.00 | 3.77 | 3.16 | 2.48 | 1.67 |
Debt / FCF Ratio | 4.73 | 4.70 | 7.62 | 6.21 | 3.52 | 2.55 |
Net Debt / Equity Ratio | 0.77 | 0.83 | 0.94 | 0.74 | 0.73 | 0.59 |
Net Debt / EBITDA Ratio | 2.44 | 2.80 | 3.47 | 2.75 | 2.31 | 1.36 |
Net Debt / FCF Ratio | 4.27 | 4.39 | 7.01 | 5.42 | 3.28 | 2.07 |
Asset Turnover | 0.70 | 0.68 | 0.65 | 0.69 | 0.75 | 0.78 |
Inventory Turnover | 36.64 | 39.10 | 35.07 | 32.46 | 32.25 | 30.53 |
Quick Ratio | 1.28 | 0.80 | 0.85 | 1.04 | 0.97 | 1.32 |
Current Ratio | 1.59 | 1.04 | 1.10 | 1.31 | 1.22 | 1.56 |
Return on Equity (ROE) | 14.66% | 14.75% | 13.84% | 14.62% | 16.15% | 30.92% |
Return on Assets (ROA) | 7.63% | 7.39% | 6.88% | 7.38% | 8.57% | 13.39% |
Return on Invested Capital (ROIC) | 9.24% | 9.03% | 8.52% | 9.26% | 10.97% | 17.84% |
Return on Capital Employed (ROCE) | 11.20% | 11.14% | 10.28% | 10.74% | 12.34% | 19.75% |
Earnings Yield | 4.21% | 5.04% | 5.10% | 5.43% | 5.09% | 8.99% |
FCF Yield | 5.36% | 7.12% | 5.43% | 5.65% | 7.57% | 8.89% |
Dividend Yield | 1.51% | 1.83% | 1.98% | 2.03% | 1.68% | 1.43% |
Payout Ratio | 35.26% | 35.58% | 38.00% | 36.77% | 32.24% | 15.49% |
Buyback Yield / Dilution | 0.88% | 0.00% | 0.00% | 4.24% | 7.81% | 5.88% |
Total Shareholder Return | 2.39% | 1.83% | 1.98% | 6.27% | 9.49% | 7.31% |